Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris
Condition: PITYRIASIS RUBRA PILARIS Intervention: Drug: Cosentyx Sponsor: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2017 Category: Research Source Type: clinical trials